Press & News

People are different and so is their cancer, patients should be treated individually.

New The power of precision, For Every Oncologist, Today

With IndiTreat, 2cureX makes the testing of chemotherapeutic agents on patient-derived microtumors an operational reality.

Latest News

Dr. Raphael Gruber joins 2cureX as new Medical Director

Latest press and news

Apr 21

IR

Regulatory

Notice of annual general meeting of 2cureX AB (publ)

Apr 21

IR

Regulatory

Swedish

Kallelse till årsstämma i 2cureX AB

Mar 14

IR

Regulatory

2cureX launches IndiTreat® mCRC Explore and completes portfolio rollout plan for 2022

Feb 24

IR

Regulatory

Report

2cureX publishes interim report for the fourth quarter and all 12 months of 2021

Feb 24

IR

Regulatory

Report

Swedish

2cureX offentliggör delårsrapport för det fjärda kvartalen och alla tolv månader 2021

Jan 21

IR

Regulatory

New Institutional shareholder

Jan 11

IR

Regulatory

IndiTreat® to be distributed in Czech Republic and Slovakia through Promedica

Jan 5

IR

Regulatory

IndiTreat® to be distributed in Poland by Perlan Technologies